VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+55.69%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.22B
AUM Growth
+$309M
(+34%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
10.33%
Top 10 Holdings %
Top 10 Hldgs %
72.94%
Holding
57
New
4
Increased
7
Reduced
9
Closed
10
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$210M |
| 2 |
Geron
GERN
|
$16.1M |
| 3 |
Tourmaline Bio
TRML
|
$15.5M |
| 4 |
SLN
Silence Therapeutics
SLN
|
$8.86M |
| 5 |
Pharvaris
PHVS
|
$7.99M |
Top Sells
| 1 |
SVA
Sinovac Biotech, Ltd
SVA
|
$38.2M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$32.5M |
| 3 |
Arcellx
ACLX
|
$18.1M |
| 4 |
Ventyx Biosciences
VTYX
|
$14.7M |
| 5 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$13.4M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sera Prognostics
SERA
$121M
| $9.87M | 0.81% |
1,650,440
-205,571
| -11% | -$1.23M |
|
27
Savara
SVRA
$665M
| $9.82M | 0.8% |
2,088,323
+174,974
| +9% | +$822K |
|
|
SLN
28
Silence Therapeutics
SLN
$254M
| $8.86M | 0.73% |
+510,204
| New | +$8.86M |
|
|
ALLK
29
DELISTED
Allakos
ALLK
| $8.16M | 0.67% |
2,988,000
| – | – |
|
|
30
Pharvaris
PHVS
$1.4B
| $7.99M | 0.65% |
+285,000
| New | +$7.99M |
|
31
Oric Pharmaceuticals
ORIC
$1.02B
| $7.82M | 0.64% |
849,681
+71,737
| +9% | +$660K |
|
|
RYZB
32
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $6.87M | 0.56% |
110,581
-522,995
| -83% | -$32.5M |
|
33
enGene Holdings
ENGN
$278M
| $6.26M | 0.51% |
+678,705
| New | +$6.26M |
|
34
Compass Therapeutics
CMPX
$590M
| $5.55M | 0.45% |
3,556,023
| – | – |
|
35
Iovance Biotherapeutics
IOVA
$861M
| $5.33M | 0.44% |
655,057
| – | – |
|
36
Instil Bio
TIL
$174M
| $4.76M | 0.39% |
624,340
+1
| +0% | +$8 |
|
37
Arrowhead Research
ARWR
$3.76B
| $4.2M | 0.34% |
137,411
| – | – |
|
38
Bolt Biotherapeutics
BOLT
$9.89M
| $3.94M | 0.32% |
176,065
-17,500
| -9% | -$392K |
|
39
Delcath Systems
DCTH
$404M
| $3.56M | 0.29% |
855,191
-1,000,000
| -54% | -$4.16M |
|
40
Rezolute
RZLT
$692M
| $3.22M | 0.26% |
3,242,842
+2,758,403
| +569% | +$2.74M |
|
41
Unicycive Therapeutics
UNCY
$77.2M
| $3.01M | 0.25% |
347,015
| – | – |
|
|
DBVT
42
DBV Technologies
DBVT
$238M
| $2.58M | 0.21% |
270,888
| – | – |
|
43
Aligos Therapeutics
ALGS
$77.2M
| $2.36M | 0.19% |
141,881
| – | – |
|
44
Codexis
CDXS
$221M
| $1.18M | 0.1% |
388,144
| – | – |
|
|
WHWK
45
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.4M
| $1.03M | 0.08% |
509,572
| – | – |
|
46
Q32 Bio
QTTB
$21.3M
| $225K | 0.02% |
20,559
| – | – |
|
47
Precision BioSciences
DTIL
$58.6M
| $51.2K | ﹤0.01% |
4,675
| – | – |
|
|
48
Arcellx
ACLX
$3.94B
| – | – |
-503,565
| Closed | -$18.1M |
|
49
Aclaris Therapeutics
ACRS
$225M
| – | – |
-898,631
| Closed | -$6.16M |
|
50
BioAtla
BCAB
$35.9M
| – | – |
-534,181
| Closed | -$908K |
|